Citation APA
André, T., Van Laethem, J.-L., Banzi, M. C. M., Maartense, E., Shmueli, E., Carlsson, G. G., Scheithauer, W., Papamichael, D., Möehler, M., Landolfi, S., Demetter, P., De Gramont, A., Colote, S., Tournigand, C., Louvet, C., Duval, A., Fléjou, J. F., de Gramont, A., Vernerey, D., Chibaudel, B., Bonnetain, F., Tijeras-Raballand, A., Scriva, A., Hickish, T., & Tabernero, J. (2015). Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: Updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. Journal of clinical oncology, 33(35), 4176-4187. doi:10.1200/JCO.2015.63.4238
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231503